Crain’s Detroit Business: FTC should examine the real factors leading to high prescription drug costs | PCMA

Crain’s Detroit Business: FTC should examine the real factors leading to high prescription drug costs

June 6, 2022

In my experience, PBMs do not contribute to the rising costs of prescription drugs—in fact, they do the exact opposite.

Pharmaceutical Care
Management Association

325 7th Street, NW
Washington, DC 20004
Main: 202.756.5700

©2024 PCMA. All Rights Reserved.